12.62
前日終値:
$13.09
開ける:
$13
24時間の取引高:
587.32K
Relative Volume:
0.76
時価総額:
$518.89M
収益:
$128.29M
当期純損益:
$-30.69M
株価収益率:
-15.39
EPS:
-0.82
ネットキャッシュフロー:
$-27.17M
1週間 パフォーマンス:
-0.08%
1か月 パフォーマンス:
+26.07%
6か月 パフォーマンス:
-11.56%
1年 パフォーマンス:
-64.84%
Rxsight Inc Stock (RXST) Company Profile
RXST を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
RXST
Rxsight Inc
|
12.62 | 538.22M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-15 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | ダウングレード | Jefferies | Buy → Hold |
| 2025-07-09 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-07-09 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-07-09 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | 開始されました | Piper Sandler | Neutral |
| 2025-04-09 | ダウングレード | UBS | Buy → Neutral |
| 2025-04-04 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2025-04-03 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-12-20 | ダウングレード | Stifel | Buy → Hold |
| 2024-12-11 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 開始されました | UBS | Buy |
| 2024-10-29 | 開始されました | Jefferies | Buy |
| 2024-08-20 | 繰り返されました | Needham | Buy |
| 2024-08-06 | 繰り返されました | Needham | Buy |
| 2024-05-07 | 繰り返されました | BTIG Research | Buy |
| 2023-12-13 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | 開始されました | Stifel | Buy |
| 2023-12-04 | 開始されました | Morgan Stanley | Overweight |
| 2023-04-13 | 開始されました | Oppenheimer | Outperform |
| 2022-12-12 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | 開始されました | Needham | Buy |
すべてを表示
Rxsight Inc (RXST) 最新ニュース
RxSight, Inc.'s (NASDAQ:RXST) 28% Price Boost Is Out Of Tune With Revenues - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Divisadero Street Capital Management LP Has $2.85 Million Stock Position in RxSight, Inc. $RXST - MarketBeat
How Does Aditya Birla Capital Limited Compare to SP500 Over the Last 3 YearsChart Pattern Recognition & Free High Yield Portfolio Picks - earlytimes.in
What Makes Mason Infratech Limited a Strong Contender in YEARInstitutional Holding Changes & Minimal Investment Portfolio - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Stockholders to Reach Out - ACCESS Newswire
RxSight, Inc. (NASDAQ:RXST) Given Average Rating of "Reduce" by Brokerages - MarketBeat
RxSight, Inc. $RXST Shares Purchased by Brown Capital Management LLC - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Stockholders to Connect - ACCESS Newswire
Why RxSight Inc. stock could benefit from AI revolution2025 Market Overview & Weekly Market Pulse Updates - Newser
RxSight price target raised to $10 from $9 at Morgan Stanley - MSN
How RxSight Inc. stock benefits from global expansion2025 Market Overview & Safe Entry Point Identification - Newser
Morgan Stanley Maintains RxSight (RXST) Equal-Weight Recommendation - Nasdaq
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RxSight (RXST) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
RxSight (RXST) Sees Analyst Rating Update from Morgan Stanley | - GuruFocus
RXST ALERT: Levi & Korsinsky Files Securities Fraud Class Action - The National Law Review
Investors SueWallSt as RxSight, Inc. Faces Securities Fraud Allegations - The National Law Review
RXST LAWSUIT ALERT: Levi & Korsinsky Notifies RxSight, Inc. InvestorsLead Plaintiff Deadline September 22, 2025 - The National Law Review
Grandeur Peak Global Advisors LLC Acquires 94,871 Shares of RxSight, Inc. $RXST - MarketBeat
Investors in RxSight, Inc. (RXST): Protect Your RightsContact Levi & Korsinsky Before September 22, 2025 - The National Law Review
RA CAPITAL MANAGEMENT, L.P.'s RxSight Inc(RXST) Holding History - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
What Analysts Say Is Shifting the Story for RxSight Shares - Yahoo Finance
Ensign Peak Advisors Inc Decreases Stock Position in RxSight, Inc. $RXST - MarketBeat
Atika Capital Management LLC Sells 158,366 Shares of RxSight, Inc. $RXST - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
RxSight, Inc. (NASDAQ:RXST) institutional owners may be pleased with recent gains after 77% loss over the past year - simplywall.st
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
SG Americas Securities LLC Purchases 30,333 Shares of RxSight, Inc. $RXST - MarketBeat
AXQ Capital LP Invests $405,000 in RxSight, Inc. $RXST - MarketBeat
What analysts say about RxSight Inc stockVolume Analysis Techniques & Hedge Fund-Style Analysis Now Free - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
76,728 Shares in RxSight, Inc. $RXST Bought by Dynamic Technology Lab Private Ltd - MarketBeat
Artisan Partners Limited Partnership Grows Position in RxSight, Inc. $RXST - MarketBeat
Midday Stock Roundup: RxSight up 14% - Orange County Business Journal
Will RxSight Inc. stock attract ESG investors2025 Performance Recap & Advanced Swing Trade Entry Plans - newser.com
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference - The Manila Times
What risks investors should watch in RxSight Inc. stockTrade Volume Summary & Detailed Earnings Play Strategies - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Shareholders to Connect - ACCESS Newswire
Is RxSight Inc. stock a defensive play in 2025Portfolio Update Report & Long-Term Safe Investment Plans - newser.com
RxSight (Nasdaq: RXST) sets Dec. 3 talk at Piper Sandler 37th Healthcare Conference - Stock Titan
Combining price and volume data for RxSight Inc.Rate Hike & Risk Managed Investment Entry Signals - newser.com
Can RxSight Inc. stock continue upward trend2025 Top Gainers & High Accuracy Buy Signal Tips - newser.com
Rxsight Inc (RXST) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):